Table 2 In vitro activity of 9 generic products of oxacillin and the innovator against two strains of S. aureus.
OXACILLIN (OXA) PRODUCTS | S. aureusATCC 29213 | S. aureusGRP-0057 | ||||
|---|---|---|---|---|---|---|
MIC (mg/L) | MBC (mg/L) | MBC/MIC Ratio | MIC (mg/L) | MBC (mg/L) | MBC/MIC Ratio | |
OXA-BMS (innovator) | 0.22 | 0.40 | 1.78 | 0.16 | 0.25 | 1.59 |
OXA-BLA | 0.50 | 0.50 | 1.00 | 0.18 | 0.50 | 2.83 |
OXA-CAR | 0.50 | 1.00 | 2.00 | 0.50 | 0.50 | 1.00 |
OXA-COL | 0.50 | 0.71 | 1.41 | 0.18 | 0.35 | 2.00 |
OXA-MEM | 0.13 | 0.13 | 1.00 | 0.13 | 0.13 | 1.00 |
OXA-OPH | 0.25 | 0.71 | 2.83 | 0.18 | 0.25 | 1.41 |
OXA-PEN | 0.25 | 0.35 | 1.41 | 0.18 | 0.21 | 1.19 |
OXA-QIM | 0.50 | 1.00 | 2.00 | 0.18 | 0.25 | 1.41 |
OXA-SER | 0.25 | 0.50 | 2.00 | 0.25 | 0.50 | 2.00 |
OXA-VIT | 0.13 | 0.13 | 1.00 | 0.13 | 0.13 | 1.00 |
Exact P (KW*) | 0.2115 | 0.2110 | 0.2611 | 0.3650 | 0.1339 | 0.2751 |